<DOC>
	<DOCNO>NCT02314702</DOCNO>
	<brief_summary>MicroPort Orthopedics ( MPO ) conduct PMCF study evaluate safety efficacy THA resurface component market EU . These type study require regulatory authority THA resurface device medium long-term clinical evidence available time gain approval market EU . This study design accordance MEDDEV 2.12/2 rev 2 .</brief_summary>
	<brief_title>Post Market Clinical Follow-Up Study Protocol PROFEMURÂ® L Revision Femoral Stems</brief_title>
	<detailed_description />
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Has undergone revision total hip arthroplasty Subject implant specified combination component Subject willing able complete require study visit assessment Subjects currently enrol another clinical study Subjects unwilling sign Informed Consent document Subjects substance abuse issue Subjects incarcerate pending incarceration</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Avascular necrosis</keyword>
	<keyword>Ankylosis</keyword>
	<keyword>Protrusio acetabuli</keyword>
	<keyword>Painful hip dysplasia</keyword>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Correction functional deformity</keyword>
	<keyword>Revision procedure</keyword>
</DOC>